Mark Juckett named medical director of the Masonic’s immuno-oncology initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Juckett was named medical director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI). 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login